Pressure BioSciences, Inc. Stock Nasdaq
Equities
US74112E1091
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | 2M 2.74M | Sales 2022 | 1.73M 2.36M | Capitalization | 15.89M 21.72M |
---|---|---|---|---|---|
Net income 2021 | -20M -27.34M | Net income 2022 | -16M -21.87M | EV / Sales 2021 | 16.4 x |
Net Debt 2021 | 14.51M 19.83M | Net Debt 2022 | 20.53M 28.06M | EV / Sales 2022 | 21.1 x |
P/E ratio 2021 |
-0.68
x | P/E ratio 2022 |
-0.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.82% |
Latest transcript on Pressure BioSciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 78-07-31 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 06-04-23 |
Chief Tech/Sci/R&D Officer | 59 | 06-04-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 78-07-31 | |
Vito Mangiardi
BRD | Director/Board Member | 75 | 12-07-02 |
Michael Urdea
BRD | Director/Board Member | 71 | 13-02-07 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |